Raymond James Financial Services Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $346K | Buy |
|
|||||
|
2024
Q2 | $314K | Buy |
|
|||||
|
2024
Q1 | $302K | Buy |
|
|||||
|
2023
Q4 | $287K | Sell |
|
|||||
|
2023
Q3 | $319K | Sell |
|
|||||
|
2023
Q2 | $360K | Buy |
|
|||||
|
2023
Q1 | $334K | Sell |
|
|||||
|
2022
Q4 | $349K | Sell |
|
|||||
|
2022
Q3 | $397K | Buy |
|
|||||
|
2022
Q2 | $414K | Sell |
|
|||||
|
2022
Q1 | $618K | Buy |
|
|||||
|
2021
Q4 | $621K | Buy |
|
|||||
|
2021
Q3 | $445K | Buy |
|
|||||
|
2021
Q2 | $461K | Sell |
|
|||||
|
2021
Q1 | $462K | Sell |
|
|||||
|
2020
Q4 | $421K | Sell |
|
|||||
|
2020
Q3 | $388K | Sell |
|
|||||
|
2020
Q2 | $424K | Sell |
|
|||||
|
2020
Q1 | $381K | Sell |
|
|||||
|
2019
Q4 | $484K | Buy |
|
|||||
|
2019
Q3 | $336K | Sell |
|
|||||
|
2019
Q2 | $468K | Buy |
|
|||||
|
2019
Q1 | $497K | Sell |
|
|||||
|
2018
Q4 | $490K | Buy |
|
|||||
|
2018
Q3 | $562K | Sell |
|
|||||
|
2018
Q2 | $621K | Sell |
|
|||||
|
2018
Q1 | $689K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.38M | Sell |
|
|||||
|
2017
Q2 | $1.42M | Sell |
|
|||||
|
2017
Q1 | $1.45M | Sell |
|
|||||
|
2016
Q4 | $1.69M | Sell |
|
|||||
|
2016
Q3 | $2.6M | Sell |
|
|||||
|
2016
Q2 | $2.76M | Sell |
|
|||||
|
2016
Q1 | $2.85M | Sell |
|
|||||
|
2015
Q4 | $3.76M | Buy |
|
|||||
|
2015
Q3 | $3.05M | Buy |
|
|||||
|
2015
Q2 | $3.07M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $1.49M | Buy |
|